Characterization of sialosylated Lewisx as a new tumor-associated antigen.
- K. Fukushima, M. Hirota, S. Hakomori
- BiologyCancer Research
- 1 November 1984
Results indicate that the CSLEX1 epitope has the following structure: These results indicate that this structure had not previously been known to be tumor associated.
Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6).
- Y. Fukushi, E. Nudelman, S. Levery, S. Hakomori, H. Rauvala
- Biology, ChemistryJournal of Biological Chemistry
- 25 August 1984
Novel Fucolipids Accumulating in Human Adenocarcinoma
- Y. Fukushi, E. Nudelman, N. Cochran
- Biology, Chemistry
- 2001
Two monoclonal antibodies, FH2 and FH3, do not discriminate among various glycolipids having fucosylated type 2 chain, and their reactivities are ess ntially similar to previously established antibodies directed to the X determinant.
Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine.
- R. Kannagi, Y. Fukushi, S. Hakomori
- Medicine, BiologyCancer Research
- 1 May 1986
The serum level of the antigen, defined by monoclonal antibody FH6 (termed sialyl LeX-i since this determinant is carried by i antigen), was significantly high in patients with cancers originating from organs from which adenocarcinomas often develop, as well as among various types of lung cancer.
Location and distribution of difucoganglioside (VI3NeuAcV3III3Fuc2nLc6) in normal and tumor tissues defined by its monoclonal antibody FH6.
- Y. Fukushi, R. Kannagi, S. Hakomori, T. Shepard, B. Kulander, J. Singer
- Biology, MedicineCancer Research
- 1 August 1985
The antigen level was found to be significantly higher in the serum of some patients with cancer, particularly lung, liver, and pancreatic cancers, as compared with the serum levels in other types of cancer, noncancerous diseases, and normal subjects.
Expression of LewisX and sialylated LewisX antigens in human colorectal polyps.
- M. Yuan, S. Itzkowitz, Y. Kim
- Medicine, BiologyJournal of the National Cancer Institute
- 1 March 1987
Extended LeX antigens and their sialylated derivatives are cancer-associated antIGens that are expressed preferentially in premalignant colon polyps that tend to correlate with malignant potential in these polyps, and that may eventually help to define mechanisms involved in the polyp-to-cancer sequence.
Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain.
- Y. Fukushi, S. Hakomori, E. Nudelman, N. Cochran
- Biology, ChemistryJournal of Biological Chemistry
- 10 April 1984
Lewisx- and sialylated Lewisx-related antigen expression in human malignant and nonmalignant colonic tissues.
- S. Itzkowitz, M. Yuan, Y. Kim
- BiologyCancer Research
- 1 May 1986
Six monoclonal antibodies recognizing long-chain polyfucosylated and sialylated LeX-related antigens appear to be useful tools for detection of colon cancer.
Coordinate expression of X and Y haptens during murine embryogenesis.
- B. Fenderson, E. Holmes, Y. Fukushi, S. Hakomori
- BiologyDevelopmental Biology
- 1 March 1986
A novel disialoganglioside (IV3NeuAcIII6NeuAcLc4) of human adenocarcinoma and the monoclonal antibody (FH9) defining this disialosyl structure.
- Y. Fukushi, E. Nudelman, S. Levery, T. Higuchi, S. Hakomori
- Biology, ChemistryBiochemistry
- 20 May 1986
This gangliosideside is highly immunogenic, and immunization of mice with this disialoganglioside fraction coated on Salmonella minnesota resulted in the establishment of a hybridoma secreting immunoglobulin G2a antibody FH9 that reacts specifically with the gang lioside antigen above.
...
...